Literature DB >> 8221779

Role of Na+/H+ exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox.

M Karmazyn1, M P Moffat.   

Abstract

Na+/H+ exchange, an electroneutral cotransport system, is activated by reperfusion of the ischaemic heart. While activation can restore intracellular pH following an acid load, the concomitant increase in intracellular Na+ can also aggravate existing derangements of ionic homeostasis, particularly with respect to calcium overload, and result in exacerbation and acceleration of tissue injury, a phenomenon which has been termed the pH paradox. In addition, Na+/H+ exchange has been shown to participate in the activation of both platelets and neutrophils, factors widely acknowledged to participate in ischaemic and reperfusion injury. All studies thus far reported (summarised in the table) have shown desirable and beneficial effects of Na+/H+ exchange inhibitors on various cellular processes which contribute to myocardial reperfusion injury. These multiple effects of Na+/H+ exchange inhibitors are unique and unmatched by any other group of pharmacological agents. They offer the hope of superior tissue protection and salvage, with limited potential for toxicity, following reperfusion protocols. We propose, therefore, that activation of the Na+/H+ exchanger mediates reperfusion injury and that suppression of the exchanger will be of superior benefit in reduction of such injury during restoration of flow. The rapid development of new and highly specific Na+/H+ exchange inhibitors offers substantial promise for the use of these agents as adjunct therapy in numerous reperfusion protocols.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8221779     DOI: 10.1093/cvr/27.6.915

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  25 in total

1.  Lethal Reperfusion Injury: Does It Exist and Does It Matter?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

2.  Does Reperfusion per se Kill Myocytes in the Heart?

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997-01       Impact factor: 2.300

3.  Myocardial protection in cardiac surgery: a historical review from the beginning to the current topics.

Authors:  Hiroshi Yamamoto; Fumio Yamamoto
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-07-23

4.  Antibodies against the cardiac sodium/bicarbonate co-transporter (NBCe1) as pharmacological tools.

Authors:  Verónica C De Giusti; Alejandro Orlowski; María C Villa-Abrille; Gladys E Chiappe de Cingolani; Joseph R Casey; Bernardo V Alvarez; Ernesto A Aiello
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 5.  Na+/H+ exchangers: physiology and link to hypertension and organ ischemia.

Authors:  I Alexandru Bobulescu; Francesca Di Sole; Orson W Moe
Journal:  Curr Opin Nephrol Hypertens       Date:  2005-09       Impact factor: 2.894

6.  Recovery from very long aortic cross-clamping in redo complex aortic surgery.

Authors:  Shoichi Suehiro; Koji Shimizu; Megumi Ito; Hayato Nakata; Kazuhiro Akeho; Teiji Oda
Journal:  Gen Thorac Cardiovasc Surg       Date:  2017-08-29

7.  Intracellular pH alterations induced by tacrine in a rat liver biliary epithelial cell line.

Authors:  D Lagadic-Gossmann; M Rissel; M Galisteo; A Guillouzo
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

Review 8.  Autophagy in ischemic heart disease.

Authors:  Asa B Gustafsson; Roberta A Gottlieb
Journal:  Circ Res       Date:  2009-01-30       Impact factor: 17.367

9.  Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte.

Authors:  D Lagadic-Gossmann; K Le Prigent; D Feuvray
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

10.  Reduced infarct size in the rabbit heart in vivo by ethylisopropyl-amiloride. A role for Na+/H+ exchange.

Authors:  E Bugge; J Munch-Ellingsen; K Ytrehus
Journal:  Basic Res Cardiol       Date:  1996 May-Jun       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.